Results: At baseline, there were minimal signs and symptoms. Maximum mean hyperemia with CAPT was 2.3 6 0.6 units (between moderate and severe) and with EEC was 1.9 6 0.5 units (approximately moderate); these maxima occurred after 30 minutes with CAPT (rapid spike) and after 180 minutes with EEC (gradual increase). Mean swelling was ,1 unit out of 4 units at all times (CAPT and EEC), and mucous discharge was observed in only 1 subject during the study (with CAPT). Maximum mean itching with both CAPT and EEC was 2.8 6 1.0 units (approximately severe), but this maximum occurred after 20 minutes with CAPT (rapid spike) and after 180 minutes with EEC (gradual increase). Maximum mean tearing with CAPT was 1.2 6 0.7 units (approximately mild) and with EEC was 1.6 6 0.6 units (between mild and moderate); these maxima occurred after 15 minutes with EEC (rapid spike) and after 120 minutes with EEC (gradual increase). Conclusions: The time courses of allergic signs and symptoms differed between CAPT and EEC models; however, both models evoked similar maximum response levels. This demonstrates that the EEC model is a useful challenge model for mimicking natural airborne ocular allergen exposure. Background: Allergic conjunctivitis (AC) is one of the most common eye disorders in clinical practice. It has been shown that AC is a disorder mediated by Th2 lymphocytes producing IL-4 and IL-5, where the eye damage is caused by a type I hypersensitivity. It has been suggested in asthma and rhinitis that T regulatory cells (Tregs) CD4 1 CD25 1 FOXP3 1 have been involved in control allergic status, favoring an optimal microenvironment with immunosuppressive cytokines (IL-10, TGF-b). However is unknown if Tregs have a role in human allergic conjunctivitis, thus it was the aim of this study. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from blood samples of healthy donors (HD) and AC-patients, and then PBMC were labeled with mAbs against CD4, CD25 and FOXP3. Labeled cells were analyzed by flow cytometry. Statistical analysis was performed with GraphPad v.5. Results: AC-patients showed 55-times more CD4 1 CD25 1 cells than HD (P ¼ 0.02). Most of CD4 1 CD25 1 were FOXP3 -(90 6 5.4), when we compared MFI of FOXP3 in CD4 1 CD25 1 cells, we observed a decreased expression in AC-patients than HD (28.5 vs 85.36, P ¼ 0.02). Conclusions: Despite we observed higher frequency of CD4 1 CD25 1 in ACpatients, these cells were FOXP3 2 , more interesting, the few cells FOXP3 1 showed a diminished MFI. These data suggest that allergic conjunctivitis status could be related with a regulatory dysfunction, as has been suggested in asthma and rhinitis. Background: Allergic conjunctivitis is one of the most common diseases affecting the ocular surface, it has been suggested that T CD41 cells regulate immune response in allergic diseases such as asthma and rhinitis, in a predominant Th2 response. In animal models, it has been observed a selective migration of CD41 T cells to conjunctiva directed by chemokines; however molecules involved in CD41 T cell migration in humans is unknown, thus it was the aim of this study. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from blood samples of healthy donors (HD) and AC-patients. PBMC were labeled with mAbs against CD4, CCR4, CCR5, and CRR9, and then labeled cells were analyzed by flow cytometry. T test was used to perform statistical analysis, P , 0.05 were considered statistically significant. Results: We observed increased frequency of CCR41 and CCR91 on PBMC cells; interestingly, expression of CCR41 was 1.46 times increased on CD41 T cells of AC-patients compared to CD41 T cells of HD (P ¼ 0.01). Similarly, we observed higher frequency of CCR9 expression on CD41 cells of AC-patients than on CD41 T cells of HD (P ¼ 0.01). On the other hand, CCR5 expression was diminished on PBMC from ACpatients than in HD (P ¼ 0.0002). Conclusions: Increased frequency of CD41 CCR41 CCR91 was observed in AC patients with diminished frequency of CCR5 expression on PBMC. CCR4 and CCR9 have been involved in inflammatory process such arthritis and asthma, both could be related to inflammatory reaction at conjunctiva. CCR5 expression is mainly on Th1 cells, diminished frequency on PBMC in allergic conjunctivitis patients could be related with imbalance of immune response favoring a Th2 chronic inflammation. Department of Ophthalmology, Tsurumi University Dental Hospital, Kanagawa, Japan. Background: Interferon-g (IFN-g) is a T helper type 1 (Th1) cytokine which has antiviral, anti-proliferative, and immunomodulatory properties. Despite the presence of IFN-g in the conjunctiva or tear fluid of patients with severe allergic conjunctivitis, the role of IFN-g in allergic conjunctivitis is controversial and enigmatic. In this study, we assess the effect of long-term treatment of IFN-g on human conjuctival fibroblasts. Methods: Primary cultured fibroblasts derived from human conjunctiva specimens were established. Cultured fibroblasts were incubated with or without IFN-g (10 ng/mL) for up to 14 days. After IFN-g treatment, cells were washed out and were re-stimulated with combinations of IL-4 (10 ng/mL) and TNFa (10 ng/mL) for 6 hours. Then, total mRNAs were isolated and mRNA expression levels were measured using a microarray and real time-PCR. Results: In IFN-g treated fibroblasts in short-term (6 hours), we confirmed the increased expression levels of well-known interferon induced genes, such as MHC class II, IRF1 and CXCL10. Increased expression of CCL11 stimulated by IL-4 1 TNFa was suppressed by short-term IFN-g treatment as described previously. In long-term (14 days) IFN-g treated cells, the expression of CCL11 and several proinflammatory chemokines, which were associated with Th2 cell and eosinophil migration, was slightly but significantly increased without any other stimulations. Interestingly, IL-4 1 TNFa stimulation greatly enhanced the expression levels of these chemokines, suggesting that long-term IFN-g treatment alters the competency of gene expression potential on these gene loci in contrast to the situation for short term treatment. Time-course analysis of IFN-g
Department of Biochemistry, Faculty of Medicine, UNAM, México D.F., Mexico. Background: Allergic conjunctivitis (AC) is one of the most common eye disorders in clinical practice. It has been shown that AC is a disorder mediated by Th2 lymphocytes producing IL-4 and IL-5, where the eye damage is caused by a type I hypersensitivity. It has been suggested in asthma and rhinitis that T regulatory cells (Tregs) CD4 1 CD25 1 FOXP3 1 have been involved in control allergic status, favoring an optimal microenvironment with immunosuppressive cytokines (IL-10, TGF-b). However is unknown if Tregs have a role in human allergic conjunctivitis, thus it was the aim of this study. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from blood samples of healthy donors (HD) and AC-patients, and then PBMC were labeled with mAbs against CD4, CD25 and FOXP3. Labeled cells were analyzed by flow cytometry. Statistical analysis was performed with GraphPad v.5. Results: AC-patients showed 55-times more CD4 1 CD25 1 cells than HD (P ¼ 0.02). Most of CD4 1 CD25 1 were FOXP3 -(90 6 5.4), when we compared MFI of FOXP3 in CD4 1 CD25 1 cells, we observed a decreased expression in AC-patients than HD (28.5 vs 85.36, P ¼ 0.02). Conclusions: Despite we observed higher frequency of CD4 1 CD25 1 in ACpatients, these cells were FOXP3 2 , more interesting, the few cells FOXP3 1 showed a diminished MFI. These data suggest that allergic conjunctivitis status could be related with a regulatory dysfunction, as has been suggested in asthma and rhinitis. Background: Allergic conjunctivitis is one of the most common diseases affecting the ocular surface, it has been suggested that T CD41 cells regulate immune response in allergic diseases such as asthma and rhinitis, in a predominant Th2 response. In animal models, it has been observed a selective migration of CD41 T cells to conjunctiva directed by chemokines; however molecules involved in CD41 T cell migration in humans is unknown, thus it was the aim of this study. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from blood samples of healthy donors (HD) and AC-patients. PBMC were labeled with mAbs against CD4, CCR4, CCR5, and CRR9, and then labeled cells were analyzed by flow cytometry. T test was used to perform statistical analysis, P , 0.05 were considered statistically significant. Results: We observed increased frequency of CCR41 and CCR91 on PBMC cells; interestingly, expression of CCR41 was 1.46 times increased on CD41 T cells of AC-patients compared to CD41 T cells of HD (P ¼ 0.01). Similarly, we observed higher frequency of CCR9 expression on CD41 cells of AC-patients than on CD41 T cells of HD (P ¼ 0.01). On the other hand, CCR5 expression was diminished on PBMC from ACpatients than in HD (P ¼ 0.0002). Conclusions: Increased frequency of CD41 CCR41 CCR91 was observed in AC patients with diminished frequency of CCR5 expression on PBMC. CCR4 and CCR9 have been involved in inflammatory process such arthritis and asthma, both could be related to inflammatory reaction at conjunctiva. CCR5 expression is mainly on Th1 cells, diminished frequency on PBMC in allergic conjunctivitis patients could be related with imbalance of immune response favoring a Th2 chronic inflammation. Department of Ophthalmology, Tsurumi University Dental Hospital, Kanagawa, Japan. Background: Interferon-g (IFN-g) is a T helper type 1 (Th1) cytokine which has antiviral, anti-proliferative, and immunomodulatory properties. Despite the presence of IFN-g in the conjunctiva or tear fluid of patients with severe allergic conjunctivitis, the role of IFN-g in allergic conjunctivitis is controversial and enigmatic. In this study, we assess the effect of long-term treatment of IFN-g on human conjuctival fibroblasts. Methods: Primary cultured fibroblasts derived from human conjunctiva specimens were established. Cultured fibroblasts were incubated with or without IFN-g (10 ng/mL) for up to 14 days. After IFN-g treatment, cells were washed out and were re-stimulated with combinations of IL-4 (10 ng/mL) and TNFa (10 ng/mL) for 6 hours. Then, total mRNAs were isolated and mRNA expression levels were measured using a microarray and real time-PCR. Results: In IFN-g treated fibroblasts in short-term (6 hours), we confirmed the increased expression levels of well-known interferon induced genes, such as MHC class II, IRF1 and CXCL10. Increased expression of CCL11 stimulated by IL-4 1 TNFa was suppressed by short-term IFN-g treatment as described previously. In long-term (14 days) IFN-g treated cells, the expression of CCL11 and several proinflammatory chemokines, which were associated with Th2 cell and eosinophil migration, was slightly but significantly increased without any other stimulations. Interestingly, IL-4 1 TNFa stimulation greatly enhanced the expression levels of these chemokines, suggesting that long-term IFN-g treatment alters the competency of gene expression potential on these gene loci in contrast to the situation for short term treatment. Time-course analysis of IFN-g treatment revealed that the treatment of IFN-g up to 24 hours suppressed the IL-4 1 TNFa-induced CCL11 expression, whereas the CCL11 expression was enhanced 3 days after the treatment. Conclusions: These results uncovered previously unsuspected contribution of IFN-g to the fibroblasts in allergic inflammatory milieu in terms of the change in production of certain chemokines. In other words, the antagonistic function of IFN-g to Th2 cells at the early phase may represent only a small part. The intracellular signaling and IFN-g-dependent secondary events are needed to be explored to explain the long-term effect or the late phase phenomenon after IFN-g administration.
Hyperosmolar Conjunctival Provocation Test (HCPT) in the Evaluation of Ocular Symptoms
Elizabeth Maria Mercer Mourão, MD, MSc, and Nelson Rosario, MD, PhD. Allergy and Immunology, Federal University of Paraná, Curitiba, Brazil. Background: Non-allergic environmental factors may cause ocular symptoms in atopic and non atopic subjects, which are known as nonspecific conjunctival hyperreactivity (CHR). This study aims to investigate the presence of CHR to the HCPT in subjects with ocular symptoms. Methods: 63 adults with ocular symptoms (itching, red eyes or tearing) were selected and tested for allergy to house dust mites and grass pollen by skin prick tests (ALK Abelló) and serum specific IgE (Immunocap-Phadia). They were considered atopic if these tests were positive to at least one allergen and non atopic if tests were negative. HCPT with 10-fold serial diluted glucose solutions was performed in all subjects until it produced conjunctival redness. Digital images were analyzed by 2 investigators (MD and technician) registering redness of the challenged eyes in red and the total area of contra-lateral eyes in blue using the fine brush tool (software GIMP 2.6.5). The number of red dots of the affected eye (%) was compared to the number of blue dots of the control eye. Results: TPCH was positive in 33/38 atopic subjects (87%) and in 4/25 non atopic (16%). Most reactions occurred at the 40% glucose solution. Sensitivity was 87% and specificity 84% (P , 0.0001). There was a significant correlation (96.5%, Pearson, P , 0.0001) between the number of red dots reported by investigators in 23 digitalized images. Conclusions: TPCH identifies CHR in both atopic and non atopic subjects. Atopic subjects exhibit CHR more frequently than non-atopic subjects. Digital images may be useful for grading ocular hyperemia in TPCH. and Maria C Jiménez-Martínez, MD, PhD 3 .
Research Unit and Department of Immunology, Institute of Ophthalmology, México D.F., Mexico; 5 Molecular Immunology Lab-I, National School of Biological Sciences, IPN, Mexico, Mexico;
6 Unidad de Desarrollo e Investigacion de Biologicos, National School of Biological Sciences, IPN, Mexico, Mexico. Background: Despite success of sublingual immunotherapy (SLIT) in the treatment of allergy diseases, more research is needed related to ocular allergy. Thus, the aim of this work was to analyze the ocular microenvironment provided by tear cytokines in allergic conjunctivitis (AC) patients treated with SLIT and to correlate tear and serum cytokines with ocular findings.
Methods: 19 AC-patients were included in this study. AC diagnosis was based on a clinical history and full ophthalmologic examination according to the diagnosis standards of the American Academy of Ophthalmology. Routine immunological studies were performed to corroborate allergic status Negative coproparasitoscopic results were documented. This study was approved by Scientific and Ethics Committees if Institute of Ophthalmology "Conde de la Valenciana," Mexico City an all subjects gave their informed consent to obtain samples. Tear and serum samples were collected to determine cytokines IL2, IL-4, IL-5, IFN-g, TNF-a, IL-10 by cytometric bead arrays (CBA), following manufacturer's instructions. Results: After 6 months of treatment with SLIT we observed significant higher IFN-g concentration, without significant changes in IL2, IL4, IL5, TNFa or IL10. We observed significant clinical improvement since 3 months of treatment and it was maintained until the end of 6 months. Clinical improvement correlated with IFN-g concentration. Conclusions: Clinical outcome in AC-patients treated with SLIT could be tear IFN-g dependent.
Vadim Sumbayev, PhD, Inna Yasinska, PhD, and Bernhard Gibbs, PhD. Medway School of Pharmacy, University of Kent, Chatham Maritime, United Kingdom. Background: Hypoxia-inducible factor 1 is a transcription complex that plays a pivotal role in cellular adaptation to low oxygen availability, which occurs during allergic responses, host immune defence and leukaemia progression. We investigated the role of HIF-1 in cellular adaptation to stress associated with different types of pathological reactions of immune cells. We studied IgEdependent responses of human mast cells and basophils, Toll-like receptor (TLR)-mediated innate immune reactions of human myeloid cells and stem cell factor (SCF)-mediated responses of hematopoietic cells of myeloid lineage. Methods: LAD2 human mast cells 1 , primary human basophils, and THP-1 human myeloid cells were used for investigations of FceRI, TLR ligand and SCF-induced responses. Quantitative real-time PCR, Western blot analysis, ELISA, fluorometry, luminometry and fluorescence microscopy were employed to run the assays. Results: We observed that HIF-1 activation is differentially regulated in the cases of pro-allergic, TLR-dependent and SCF-induced cellular responses. While PI3K/mTOR and MAP kinase pathways were the major contributors to HIF-1 activation during allergic/SCF-dependent responses, TLR-mediated processes occurred mostly via redox-dependent mechanisms. Experiments with HIF-1a (the inducible subunit regulating HIF-1 transactivation) knockdown cells demonstrated that HIF-1 plays a crucial role in the expression of the primary angiogenic cytokine VEGF and controls intracellular energy metabolism by regulating glycolytic metabolic activity. Conclusions: The HIF-1 transcription complex supports not only the survival of immune cells (mast cells, basophils, myeloid cells) in pathological environments but also determines their abilities to generate pro-allergic, pro-inflammatory as well as pro-angiogenic cytokines over sustained periods.
